Listing 1 - 10 of 13 | << page >> |
Sort by
|
Choose an application
Choose an application
Our study clearly establishes that the one-third partial hepatectomy is of particular interest in the study of the regenerative response, as In contrast to the two-thirds partial hepatectomy, it can easily be amplified by various factors.
In the first part, infusion of Diprivan (Propofol) increases the DNA synthesis in 10% partial hepatectomy from control value 13.2+/-1.8 to 54.5+/-7.7 (P<0.01),in one-third partial hepatectomy from 41.5+/-3.1 to 102.7+/-11.5 (P<0.001), in sham operation from 7.2+/-1.7 to 23.1+/-3.4 (P<0.01) but not after a two-thirds partial hepatectomy. Infusion in Intralipid emulsion alone also increases the DNA synthesis in 10% partial hepatectomy from 13.2+/-1.8 to 24.3+/-2.0 (P<0.01), in one-third partial hepatectomy from 7.2+/-1.7 to 20.4+/-4.2 (P<0.5) but not in two-thirds partial hepatectomy.
In the second part, a stimulatory effect of HGF administration on the DNA synthesis after a one-third partial hepatectomy, is obtained by two injections, immediately and at 12 hours (from control value 41+/-3.1 to 143+/-27.2 (P<0.001), by continuous infusion during 24 hours (to 109+/-20 P<0.01) or by a single injection at the 10th hour (to 105+/-19.5 O<0.01). By contrast, the administration immediately after the one-third partial hepatectomy seems much less efficient (65+/-18.8).
In the third part, the conversion of one-third into a two-third partial hepatectomy obtains a 24-jour response identical to the one after classic two-thirds partial hepatectomy (315+/-24 versus 333+/-18). By contrast, when the conversion is delayed at 14 hours, this response is markedly reduced (50+/-13).
These results suggest that the one-third partial hepatectomy is an interesting model which is more sensitive and it is susceptible to be modified by various factors such a Diprivan, Intralipid. The magnitude of the regenerative response to a one-third partial hepatectomy is easily modified at around the 10th hour by the administration of HGF or by the further reduction of the liver mass.
Hepatectomy --- Propofol --- Hepatocyte Growth Factor --- Liver Regeneration
Choose an application
Insulin --- Liver cells --- Liver Diseases --- Liver --- Cell division --- Glucagon --- Glycogenosis --- Liver regeneration --- Physiological effect --- Congresses. --- Regeneration --- Drug effects --- Pharmacodynamics --- Liver Regeneration --- Glycogen Storage Disease --- Cell Division
Choose an application
HEPATITIS, VIRAL, HUMAN --- LIVER DISEASES --- CHRONIC DISEASE --- LIVER REGENERATION --- HEPATITIS VIRUSES --- ETHANOL --- ADVERSE EFFECTS
Choose an application
FGF19 (fibroblastes growth factor) and its murine homologue FGF15 are members of the subfamily of FGF19 with endocrine action. FGF15 and 19 have a similar expression pattern and they regulate glucose metabolism and bile acids (BA) in a similar way. FGF15/19 plays a cruciale role in the regulating the bile acid pool. Indeed, its expression is induced in the intestine by the acid receptor FXR (Farnesoid X Receptor). FGF15/19 is then released into the circulation and inhibits the expression of CYp7al (the rate-limiting enzyme in the classical pathway of BA synthesis) in the liver. Iker Uriarte et al. Pinpointed that FGF15 is a critical hormone in modulating the rate of BA during liver regeneration. Therefore, we questioned whether FGF15/19 could have an impact on the proliferation and differentiation of progenitor cells into hepatocytes and cholangiocytes. In order to assess this hypothesis we evaluated the effect of recombinant FGF19 (r FGF19) injections on progenitor cells in a murine model hepatotocixity. We exposed C57BL/6J mice to a choline-deficient, ethionine-supplemented diet (CDE) during 23 days to stimulate expansion of progenitor cells.During the last 11 days mice were injected with PBS or rFGF19.This preliminary experiment showed that: 1) rFGF19 injections are well tolerated, 2) the rFGF19 is active in mice, it is detected in treated mice’s serum (whereas it’s undetectable in control mice) and inhibits effectively the expression of Cyp7al in the liver. By using the localization in the CDE model we did not observe any evident effect produced by rFGF19: LPC seem to have a similar localization in the CDE mice treated with rFGF19 compared to thecontrols. Moreover, both mice groups present a comparable number of LPC. We could continue our study by analyzing the effects in a different mouse model (OPN-iCreERT2; Rosa26RYFP- that allows tracking the fate of progenitor cells, so as to evaluate the impact of FGF19 on the differentiation of progenitor cells in hepatocytes. Le FGF19 (facteur de croissance des fibroblastes – fibroblastes growth factor) ou son homologue murin, FGF15 sont membres de la sous famille du FGF19 à action endocrine. Les ARN messagers (ARNm) de FGF15 et FGF19 sont des profils d’expression similaires et régulent de la même façon le métabolisme du glucose et des acides biliaires. FGF15/ FGF19 joue un rôle important dans la régulation du pool des acides biliaires. En effet, son expression est induite dans l’intestin par le récepteur aux acides biliaires FXR (Farnesoid X Receptor). Il est alors relargué dans la circulation et va inhiber l’expression de CYp7al dans le foie, enzyme de synthèse des acides biliaires. Iker Uriarte et al. ont identifié FGF15 comme une hormone essentielle dans la modulation du taux de BA au cours de la régénération du foie. Nous proposons que le FGF15 pourrait influencer la prolifération et la différenciation des cellules progénitrices en hépatocytes et cholangiocytes. Pour évaluer cette question nous avons évalué l’effet de l’administration de FGF19 recombinant sur les cellules progénitrices dans un modèle murin d’hépatotoxicité. Nous avons exposé des souris C57BL6J à un régime déficient en choline supplémentée en éthionine (CDE), pendant 23 jours pour induire l’expansion des cellules progénitrices. Pendant les 11 derniers jours, les souris ont été injectées avec du rFGF19 humain ou du PBS. Cette expérience préliminaire a permis de montrer que 1) les injections de rFGF19 sont bien tolérées, 2) que le rFGF19 est fonctionnel chez la souris : il est détecté dans le sérum des souris traitées (indétectables dans les souris contrôles) et inhibe bien l’expression de Cyp7al dans le foie. Dans un modèle d’induction des cellules progénitrices, nous n’avons pas observé d’effet évident du rFGF19 : les LPC semblent aussi nombreuses et ont une localisation similaire chez les souris CDE traitées au rFGF19 ou non. On pourrait continuer notre étude en allant à analyser la réponse de modèle des souris différents (OPN-IcreERT2 ; Rosa26RYFP) qui permet de suivre le devenir des cellules progénitrices, et ainsi d’évaluer l’effet de FGF19 sur la différenciation des cellules pro génitrices en hépatocytes.
fibroblast growth factor 15, mouse --- FGF19 protein, human --- Hematopoietic Stem Cells --- Liver Regeneration --- Review
Choose an application
Because of its marked capacity to regenerate and the ability of chemical carcinogens and viruses to ready transform hepatocytes, the liver has been used extensively as a model for investigating the molecular mechanisms of cellular proliferation and carcinogenesis. Recently, striking advances have occured in the understanding of hepatocyte growth regulation and the manner in which chemical agents and viruses alter these normal growth regulatory pathways in liver carcinogenesis. This explosion of information has occured in a multitude of research disciplines. This book brings together current fin
Liver. --- Liver Neoplasms. --- Liver Regeneration. --- Liver--Cancer. Liver--Regeneration. Pathology, Molecular. Liver--Molecular aspects. Liver Regeneration. Liver Neoplasms--genetics. --- Pathology, Molecular. --- Liver --- Pathology, Molecular --- Liver Regeneration --- Genetics --- Liver Neoplasms --- Biology --- Digestive System Neoplasms --- Liver Diseases --- Regeneration --- Digestive System Processes --- Digestive System Diseases --- Digestive System Physiological Phenomena --- Neoplasms by Site --- Biological Processes --- Biological Science Disciplines --- Neoplasms --- Biological Phenomena --- Diseases --- Digestive System and Oral Physiological Phenomena --- Natural Science Disciplines --- Phenomena and Processes --- Disciplines and Occupations --- Oncology --- Medicine --- Health & Biological Sciences --- Cancer --- Molecular aspects --- Cancer. --- Molecular aspects. --- Regeneration. --- Molecular pathology --- Hepatic regeneration --- Hepatocellular carcinoma --- Molecular biology --- Physiology, Pathological --- Abdomen --- Biliary tract
Choose an application
The Hepatic circulation is unique among vascular beds. The most obvious unique features include the dual vascular supply; the mechanism of intrinsic regulation of the hepatic artery (the hepatic arterial buffer response); the fact that portal blood flow, supplying two thirds of liver blood flow, is not controlled directly by the liver; the fact that 20% of the cardiac output rushes through the most vascularized organ in the body, driven by a pressure gradient of only a few millimeters of mercury; the extremely distensible capacitance and venous resistance sites; the unidirectional acinar blood flow that regulates parenchymal cell metabolic specialization; and the high concentration of macrophagic (Kupffer) cells filtering the blood. The liver is the only organ reported to have regional blood flow monitored by the autonomic nervous system. This mechanism, when dysfunctional, accounts for the hepatorenal syndrome and offers a mechanistic therapeutic target to treat this syndrome. The trigger for liver regeneration is dependent on hepatic hemodynamics so that chronic liver blood flow regulates liver cell mass. In severe liver disease, the whole body circulation is reorganized, by forming portacaval shunts, to accommodate the increased intrahepatic venous resistance. These shunts protect the venous drainage of the splanchnic organs but lead to loss of major regulatory roles of the liver. The development of knowledge of the hepatic vasculature is presented from a historical perspective with modern concepts summarized based on the perspective of the author's four decades of devotion to this most marvelous of organs.
Liver --- Blood-vessels. --- Hepatic artery. --- Liver Circulation. --- Hepatic Artery. --- Hepatic artery --- Portal vein --- Hepatorenal syndrome --- Liver regeneration --- Hepatic arterial buffer response
Choose an application
Liver Regeneration: Basic Mechanisms, Relevant Models and Clinical Applications presents cutting-edge information on liver regeneration research through an integrated, systems-wide perspective. The book addresses discoveries on hepatic progenitor cells, liver regeneration after chemical damage, and liver regeneration as a prime therapy for liver failure and disease. By addressing the urgent need for translating basic research findings into clinically relevant modalities and potential therapeutic applications, the book provides the data needed to improve liver patient management. Hundre
Liver -- Diseases. --- Liver -- Regeneration. --- Stem cells. --- Liver Regeneration --- Computer Simulation --- Stem Cells --- Cells --- Computing Methodologies --- Digestive System Processes --- Regeneration --- Information Science --- Anatomy --- Biological Processes --- Digestive System Physiological Phenomena --- Digestive System and Oral Physiological Phenomena --- Biological Phenomena --- Phenomena and Processes --- Liver --- Regeneration. --- Hepatic regeneration
Choose an application
Developments in tissue engineered and regenerative medicine products summarizes recent developments in tissue engineering and regenerative medicine with an emphasis on commercialization and product development. Features of current cell therapy and tissue engineered products which have facilitated successful commercialization are emphasized and roadblocks to successful product development are also highlighted. Preclinical and clinical testing of tissue engineered and regenerative medicine products, regulatory, quality control, manufacturing issues, as well as generating and securing intellectua
Liver -- growth & development. --- Liver Regeneration. --- Regenerative Medicine -- methods. --- Stem Cells -- physiology. --- Tissue engineering --- Regenerative medicine --- Culture Techniques --- Medicine --- Health Occupations --- Clinical Laboratory Techniques --- Disciplines and Occupations --- Investigative Techniques --- Analytical, Diagnostic and Therapeutic Techniques and Equipment --- Regenerative Medicine --- Tissue Engineering --- Health & Biological Sciences --- Biomedical Engineering --- Regenerative medicine. --- Tissue engineering. --- Biomedical engineering --- Tissue culture --- Regeneration (Biology)
Choose an application
The aim of this Special Issue is to review, understand, and evaluate new and exciting opportunities from the field on regenerative medicine, biomaterials, and stem cell research for the bioengineering of human liver grafts that can be applied for transplantation and personalized treatment of end-stage liver disease.The development of culture conditions for long-term expansion of LGR5+ intestinal stem cells as crypt-villus structures demonstrated the feasibility of deriving complex, organ-like structures in vitro from primary adult tissues, including the liver. Moreover, human pluripotent stem cells (hPSCs) can be applied to generate functionally maturated liver and bile duct epithelial cells.In this Special Issue, we welcome reviews and original papers focussing on hepatic cell sources, including adult hepatic stem cells, organoids, fetal and induced pluripotent stem cells, and primary cells (i.e., hepatocytes, cholangiocytes, and endothelial cells) and how these cells can be applied in tissue engineering strategies to generate implantable and personalized liver grafts. Potential topics include, but are not limited to, the following: liver tissue engineering, liver regeneration, graft repair, liver stem cells and organoids, bio-scaffolds, and 3D printing.We invite you to contribute original research papers, as well as comprehensive reviews, aligned with these themes, to advance and improve the actual state-of-the-art in liver bioengineering and providing new opportunities for the imminent medical problem of organ and tissue shortage for transplantation.
n/a --- tissue engineering --- regenerative medicine --- liver tissue bioengineering --- additive manufacturing --- copper toxicosis --- hepatobiliary stent --- reconditioning --- medical device --- liver regeneration --- Wilson Disease --- stem cells --- preclinical large animal model --- liver --- stem cell transplantation --- liver bioreactors --- personalized medicine --- direct printing --- hydrogel --- 3D structuring --- oxygen persufflation --- end-stage liver diseases --- 3D printing --- liver transplantation --- bioengineered organ --- randomized controlled trail
Listing 1 - 10 of 13 | << page >> |
Sort by
|